Celldex Therapeutics (CLDX) Q4 2016 Earnings

7NovConfirmed
Q1 2016
Q2 2016
Aug 16
Q4 2016
-5.25
-3.61
-1.96
-0.32

Details

Expected EPS
-5.01
Actual EPS
-4.35
Surprise EPS
0.66
Surprise Percent
+13.17%

Description

Celldex Therapeutics (CLDX) has reported earnings of -4.35 per share for Q4 2016.

0 Comments

Share your thoughts